Acceder

Publicaciones - FARMACOCINETICA CLINICA Y FARMACOTERAPIA APLICADA

Cargando...
Ortiz-Fernandez P, Iniesta-Navalon C, Urbieta-Sanz E, Gascon-Canovas JJ. Assessing early therapeutic drug monitoring of adalimumab as a predictor of treatment efficacy and immunogenicity in rheumatic diseases. Clin Rheumatol. 2025 Aug;44(8):3389-3390. doi: 10.1007/s10067-025-07559-w. Epub 2025 Jul 4. No abstract available. PubMed PMID: 40613968.
AÑO: 2025; IF: 2.8
40613968
Iniesta-Navalon C, Rios-Saorin M, Anez-Castano R, Rentero-Redondo L, Ortiz-Fernandez P, Marin-Armero Martinez E, Urbieta-Sanz E. Evaluating the Accuracy and Clinical Utility of AFIAS-10 Point of Care Versus Enzyme-Linked Immunosorbent Assay in Therapeutic Drug Monitoring of Infliximab and Adalimumab. Ther Drug Monit. 2025 Jun 1;47(3):346-352. doi: 10.1097/FTD.0000000000001269. Epub 2024 Nov 15. PubMed PMID: 40341590.
AÑO: 2025; IF: 2.4
40341590
Iniesta-Navalon C, Rios-Saorin M, Rentero-Redondo L, Gascon-Canovas JJ, Gonzalez-Molina MR, Prado IN, Gomez-Espin R, Urbieta-Sanz E. STRATIfy-PK SCORE: A predictive tool for identifying pharmacokinetic failure risk in anti-TNF-treated patient. Br J Clin Pharmacol. 2025 Nov 21. doi: 10.1002/bcp.70346. Online ahead of print. PubMed PMID: 41268891.
AÑO: 2025; IF: 3.0
41268891
Ortiz-Fernandez P, Iniesta-Navalon C, Urbieta-Sanz E, Gascon-Canovas JJ. Assessing early therapeutic drug monitoring of adalimumab as a predictor of treatment efficacy and immunogenicity in rheumatic diseases: "early therapeutic drug monitoring of adalimumab". Clin Rheumatol. 2025 Jan 18. doi: 10.1007/s10067-025-07307-0. Online ahead of print. PubMed PMID: 39826047.
AÑO: 2025; IF: 2.8
39826047
Serrano Díaz L., Iniesta Navalón C., Gómez Espín R., Nicolás De Prado I., Bernal Morell E., Rentero Redondo L. Comparative effectiveness and drug survival of biosimilar infliximab CPT-13 vs. reference infliximab in inflammatory bowel disease: A retrospective cohort study. Gastroenterologia y Hepatologia. 1 June 2024. 47:553-561. 10.1016/j.gastrohep.2023.08.004
AÑO: 2024; IF: 2.2
37597745
< AnteriorSiguiente >
IMIB-Arrixaca

Instituto de Investigación Sanitaria Acreditado

ISCII

FARMACOCINETICA CLINICA Y FARMACOTERAPIA APLICADA